The main goal of the Survey Research Core (SRC), located at the AMC Cancer Research Center, is to provide technical assistance and services to UCCC members in collecting research data, with specialized expertise in computer-assisted telephone interviews (CATI). The SRC collaborates in testing the effectiveness of cancer related health education and behavioral interventions delivered by telephone. Since its inception as a UCCC Core resource in the Year 2000, the SRC has shown sustained growth in utilization, providing support to 20 peer-reviewed cancer-related studies conducted by 12 different Principal Investigators affiliated with the UCCC. In these studies the SRC has conducted over 26,000 cancer-related telephone interviews. The number of cancer-related interviews completed by the SRC in Year 2004 exceeded 10,000, representing a 14-fold increase in utilization compared to the Year 2000. In the current operating budget the SRC gets 28% of its funding from the UCCC as a core resource, 55% from grants and contracts, and 17% from other UCCC institutional resources (Cancer Center gift funds and institutional support from AMC, a Consortium Cancer Center member institution). UCCC core funds provide partial support for consultation services, management, and oversight of this resource. All interviewer positions are 100% funded by grants and contracts. Future plans include: 1. expanding utilization of the SRC by UCCC members across a broader range of program areas (e.g. by using the SRC to conduct follow-up of patients in clinical trials) 2. using the SRC to test telephone education and counseling interventions across the full spectrum of cancer prevention and control 3. using the SRC to develop and test telephone-delivered patient navigation, support and referral interventions 4. expanding SRC capacity to conduct web-based surveys and interventions.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
United States
Zip Code
Finlay-Schultz, J; Cittelly, D M; Hendricks, P et al. (2015) Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. Oncogene 34:3676-87
Alvarez-Calderon, Francesca; Gregory, Mark A; Pham-Danis, Catherine et al. (2015) Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations. Clin Cancer Res 21:1360-72
Kumar, Sushil; Raina, Komal; Agarwal, Chapla et al. (2014) Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals. Oncotarget 5:4972-89
Roth, Lauren W; Allshouse, Amanda A; Bradshaw-Pierce, Erica L et al. (2014) Luteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight women. Clin Endocrinol (Oxf) 81:418-25
Roth, Lauren W; Bradshaw-Pierce, Erica L; Allshouse, Amanda A et al. (2014) Evidence of GnRH antagonist escape in obese women. J Clin Endocrinol Metab 99:E871-5
Colussi, Timothy M; Costantino, David A; Hammond, John A et al. (2014) The structural basis of transfer RNA mimicry and conformational plasticity by a viral RNA. Nature 511:366-9
Griesinger, Andrea M; Donson, Andrew M; Foreman, Nicholas K (2014) Immunotherapeutic implications of the immunophenotype of pediatric brain tumors. Oncoimmunology 3:e27256
Marek, Lindsay A; Hinz, Trista K; von Mässenhausen, Anne et al. (2014) Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma. Mol Cancer Res 12:1460-9
Holliday, Michael J; Zhang, Fengli; Isern, Nancy G et al. (2014) 1H, 13C, and 15N backbone and side chain resonance assignments of thermophilic Geobacillus kaustophilus cyclophilin-A. Biomol NMR Assign 8:23-7
Milgroom, Andrew; Intrator, Miranda; Madhavan, Krishna et al. (2014) Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent. Colloids Surf B Biointerfaces 116:652-7

Showing the most recent 10 out of 678 publications